Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2

P. Potalitsyn, L. Mrázková, I. Selicharová, M. Tencerová, M. Ferenčáková, M. Chrudinová, T. Turnovská, AM. Brzozowski, A. Marek, J. Kaminský, J. Jiráček, L. Žáková

. 2023 ; 6 (1) : 863. [pub] 20230819

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc23016539

Grant support
BB/W003783/1 Biotechnology and Biological Sciences Research Council - United Kingdom
MR/R009066/1 Medical Research Council - United Kingdom

Insulin-like Growth Factor-2 (IGF2) is important for the regulation of human embryonic growth and development, and for adults' physiology. Incorrect processing of the IGF2 precursor, pro-IGF2(156), leads to the formation of two IGF2 proforms, big-IGF2(87) and big-IGF2(104). Unprocessed and mainly non-glycosylated IGF2 proforms are found at abnormally high levels in certain diseases, but their mode of action is still unclear. Here, we found that pro-IGF2(156) has the lowest ability to form its inactivating complexes with IGF-Binding Proteins and has higher proliferative properties in cells than IGF2 and other IGF prohormones. We also showed that big-IGF2(104) has a seven-fold higher binding affinity for the IGF2 receptor than IGF2, and that pro-IGF2(87) binds and activates specific receptors and stimulates cell growth similarly to the mature IGF2. The properties of these pro-IGF2 forms, especially of pro-IGF2(156) and big-IGF2(104), indicate them as hormones that may be associated with human diseases related to the accumulation of IGF-2 proforms in the circulation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016539
003      
CZ-PrNML
005      
20231026105735.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s42003-023-05239-6 $2 doi
035    __
$a (PubMed)37598269
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Potalitsyn, Pavlo $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic $u Department of Biochemistry, Faculty of Science, Charles University, 12800, Prague 2, Czech Republic $1 https://orcid.org/0000000247036559
245    10
$a Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2 / $c P. Potalitsyn, L. Mrázková, I. Selicharová, M. Tencerová, M. Ferenčáková, M. Chrudinová, T. Turnovská, AM. Brzozowski, A. Marek, J. Kaminský, J. Jiráček, L. Žáková
520    9_
$a Insulin-like Growth Factor-2 (IGF2) is important for the regulation of human embryonic growth and development, and for adults' physiology. Incorrect processing of the IGF2 precursor, pro-IGF2(156), leads to the formation of two IGF2 proforms, big-IGF2(87) and big-IGF2(104). Unprocessed and mainly non-glycosylated IGF2 proforms are found at abnormally high levels in certain diseases, but their mode of action is still unclear. Here, we found that pro-IGF2(156) has the lowest ability to form its inactivating complexes with IGF-Binding Proteins and has higher proliferative properties in cells than IGF2 and other IGF prohormones. We also showed that big-IGF2(104) has a seven-fold higher binding affinity for the IGF2 receptor than IGF2, and that pro-IGF2(87) binds and activates specific receptors and stimulates cell growth similarly to the mature IGF2. The properties of these pro-IGF2 forms, especially of pro-IGF2(156) and big-IGF2(104), indicate them as hormones that may be associated with human diseases related to the accumulation of IGF-2 proforms in the circulation.
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    12
$a insulinu podobný růstový faktor II $7 D007335
650    _2
$a proliferace buněk $7 D049109
650    _2
$a buněčný cyklus $7 D002453
650    12
$a mezibuněčné signální peptidy a proteiny $7 D036341
650    _2
$a mitogeny $7 D008934
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mrázková, Lucie $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic $u Department of Cell Biology, Faculty of Science, Charles University, 12800, Prague 2, Czech Republic
700    1_
$a Selicharová, Irena $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic
700    1_
$a Tencerová, Michaela $u Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic $1 https://orcid.org/000000018670425X
700    1_
$a Ferenčáková, Michaela $u Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic
700    1_
$a Chrudinová, Martina $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic
700    1_
$a Turnovská, Tereza $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic
700    1_
$a Brzozowski, Andrzej Marek $u York Structural Biology Laboratory, Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK $1 https://orcid.org/0000000174268948
700    1_
$a Marek, Aleš $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic
700    1_
$a Kaminský, Jakub $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic
700    1_
$a Jiráček, Jiří $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic. jiracek@uochb.cas.cz $1 https://orcid.org/0000000338482773 $7 xx0098873
700    1_
$a Žáková, Lenka $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 116 10, Prague 6, Czech Republic. zakova@uochb.cas.cz $1 https://orcid.org/0000000164392574
773    0_
$w MED00197237 $t Communications biology $x 2399-3642 $g Roč. 6, č. 1 (2023), s. 863
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37598269 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105730 $b ABA008
999    __
$a ok $b bmc $g 2000198 $s 1202901
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 6 $c 1 $d 863 $e 20230819 $i 2399-3642 $m Communications biology $n Commun Biol $x MED00197237
GRA    __
$a BB/W003783/1 $p Biotechnology and Biological Sciences Research Council $2 United Kingdom
GRA    __
$a MR/R009066/1 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20231013
Back

Find record

Citation metrics

Archiving options